Nephros (NEPH) Total Non-Current Liabilities (2010 - 2020)
Nephros (NEPH) posted quarterly Total Non-Current Liabilities of -$5.3 million for Q4 2020, down 245.93% year-over-year from $3.6 million in Q1 2020, and down 239.94% quarter-over-quarter from $3.8 million in Q3 2020.
Nephros (NEPH) Total Non-Current Liabilities (2010 - 2020) Analysis & Trends
Nephros' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at -$5.3 million for Q4 2020.
- In Q4 2020, Total Non-Current Liabilities fell 245.93% year-over-year to -$5.3 million; the TTM figure through Dec 2020 stood at -$5.3 million (down 245.93% YoY), while the FY2020 annual figure was -$5.3 million, down 245.93% from the prior year.
- Total Non-Current Liabilities for Q4 2020 stood at -$5.3 million, down from $3.8 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $5.0 million in Q2 2019, with the low at -$5.3 million in Q4 2020.
- The 3-year median for Total Non-Current Liabilities is $4.2 million (2020), against an average of $3.2 million.
- The sharpest annual moves came in 2019 and 2020: Total Non-Current Liabilities rose 4.09% in 2019, then plunged 245.93% in 2020.
- Nephros' Total Non-Current Liabilities stood at $3.5 million in 2018, then rose by 4.09% to $3.6 million in 2019, then slumped by 245.93% to -$5.3 million in 2020.
- Business Quant data shows NEPH's Total Non-Current Liabilities at -$5.3 million in Q4 2020, $3.8 million in Q3 2020, and $4.2 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.20 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.59 Bn | 51.72 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.74 Bn | 34.38 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.69 Bn | 32.22 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.14 Bn | 26.46 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.05 Bn | 24.62 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.41 Bn | 15.01 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Nephros | 43.86 Mn | 39.16 Mn | 4.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -5.31 Mn |
| Sep 30, 2020 | 3.80 Mn |
| Jun 30, 2020 | 4.19 Mn |
| Mar 31, 2020 | 4.46 Mn |
| Dec 31, 2019 | 3.64 Mn |
| Sep 30, 2019 | 4.75 Mn |
| Jun 30, 2019 | 5.05 Mn |
| Mar 31, 2019 | 4.30 Mn |
| Dec 31, 2018 | 3.50 Mn |
| Sep 30, 2015 | -3.77 Mn |
| Jun 30, 2015 | 1.75 Mn |
| Mar 31, 2015 | 1.66 Mn |
| Dec 31, 2014 | 1.66 Mn |
| Sep 30, 2014 | -3.63 Mn |
| Jun 30, 2014 | -8.41 Mn |
| Mar 31, 2014 | -3.57 Mn |
| Dec 31, 2013 | 3.59 Mn |
| Sep 30, 2013 | -5.65 Mn |
| Jun 30, 2013 | -3.94 Mn |
| Mar 31, 2013 | -939,000.00 |